Lubaba A. Zaman
YOU?
Author Swipe
View article: Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV‐1 Proviral DNA Excision
Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV‐1 Proviral DNA Excision Open
Advancements in antiretroviral therapy (ART) enable those living with the human immunodeficiency virus type one (HIV‐1) to lead longer, healthier lives free from disease comorbidities. However, lifelong ART poses challenges. These include …
View article: CCR5-ligand decorated rilpivirine lipid-based nanoparticles for sustained antiretroviral responses
CCR5-ligand decorated rilpivirine lipid-based nanoparticles for sustained antiretroviral responses Open
View article: Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV-1 Proviral DNA Excision
Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV-1 Proviral DNA Excision Open
View article: CCR5 Decorated Rilpivirine Lipid Nanoparticles Build Myeloid Drug Depots Which Sustains Antiretroviral Activities
CCR5 Decorated Rilpivirine Lipid Nanoparticles Build Myeloid Drug Depots Which Sustains Antiretroviral Activities Open
View article: Polymer Delivery Systems for Long-Acting Antiretroviral Drugs
Polymer Delivery Systems for Long-Acting Antiretroviral Drugs Open
The success of long-acting (LA) drug delivery systems (DDSs) is linked to their biocompatible polymers. These are used for extended therapeutic release. For treatment or prevention of human immune deficiency virus type one (HIV-1) infectio…
View article: Polymer Delivery Systems for Long-Acting Antiretroviral Drugs
Polymer Delivery Systems for Long-Acting Antiretroviral Drugs Open
Long-acting (LA) drug-delivery system (DDS) successes are linked to their abilities to harness biocompatible polymers and materials for sustained and predictable release of therapeutic agents over an extended period of time. For human immu…
View article: Polymer Delivery Systems for Long-Acting Antiretroviral Drugs
Polymer Delivery Systems for Long-Acting Antiretroviral Drugs Open
Long-acting (LA) drug-delivery system (DDS) successes are linked to their abilities to harness biocompatible polymers and materials for sustained and predictable release of therapeutic agents over an extended period of time. For human immu…
View article: Delivery of gene editing therapeutics
Delivery of gene editing therapeutics Open
View article: Humanized Mice for Studies of HIV-1 Persistence and Elimination
Humanized Mice for Studies of HIV-1 Persistence and Elimination Open
A major roadblock to achieving a cure for human immunodeficiency virus type one (HIV-1) is the persistence of latent viral infections in the cells and tissue compartments of an infected human host. Latent HIV-1 proviral DNA persists in res…
View article: The CXCR1 Axis: A Putative Therapeutic Cancer Stem Cell-Like Marker in Pancreatic Ductal Adenocarcinoma
The CXCR1 Axis: A Putative Therapeutic Cancer Stem Cell-Like Marker in Pancreatic Ductal Adenocarcinoma Open
Pancreatic ductal adenocarcinoma (PDAC) has one of the lowest survival rates of all cancers in the United States. Not only is PDAC found at the late stages, but patients also present with or develop chemotherapy resistance at an elevated f…